Schedule 13G ownership disclosure

REGENERON PHARMACEUTICALS COM

Security class unavailable · CUSIP: 75886F107

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,931,220
Percent of class
7.5600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-018970
Form type
SC 13G/A
Filer
REGENERON PHARMACEUTICALS, INC.
CIK
CIK 872589
Filed
Feb 10, 2021
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub